Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication, and strategies for difficult-to-treat patients.

MLA

UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, et al. “Inhibitors in Haemophilia A and B: Management of Bleeds, Inhibitor Eradication, and Strategies for Difficult-to-Treat Patients.” European Journal of Haematology, Vol. 102, No. 2, p. 111-122 (2019), 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130448149&authtype=sso&custid=ns315887.

APA

UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, UCL - (SLuc) Service d’hématologie, UCL - (SLuc) Centre de malformations vasculaires congénitales, Ljung, R., Auerswald, G., Benson, G., Dolan, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Lambert, T., Morfini, M., Zupančić-Šalek, S., & Santagostino, E. (2019). Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication, and strategies for difficult-to-treat patients. European Journal of Haematology, Vol. 102, No. 2, p. 111-122 (2019).

Chicago

UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, UCL - (SLuc) Service d’hématologie, UCL - (SLuc) Centre de malformations vasculaires congénitales, Rolf Ljung, Guenter Auerswald, Gary Benson, Gerry Dolan, et al. 2019. “Inhibitors in Haemophilia A and B: Management of Bleeds, Inhibitor Eradication, and Strategies for Difficult-to-Treat Patients.” European Journal of Haematology, Vol. 102, No. 2, p. 111-122 (2019). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130448149&authtype=sso&custid=ns315887.